Publications by authors named "Jayanti Gurumukhani"
Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experience.
Epilepsy Behav
May 2022
Article Synopsis
- The study aimed to evaluate the effectiveness and safety of clobazam as an add-on therapy for patients with epilepsy whose seizures were not well-controlled by single antiseizure medications (ASM).
- Conducted in India, the research followed 429 patients over one year, assessing seizure control and adverse effects through interviews and diaries.
- Results showed that 83.4% of the patients remained seizure-free after one year, and clobazam was well-tolerated, although 22.6% experienced adverse events.
Aims: To study the impact of vestibular suppressant drugs (VSD) on provocative positional tests (PPT) in patients with benign paroxysmal positional vertigo (BPPV).
Settings And Design: A prospective case-control observational study.
Materials And Methods: Patients with a history suggestive of BPPV were tested for PPT.
Medicated adhesive dressing is a safe and non-inferior cutaneous seal as compared to compound tincture benzoin dermal seal for percutaneous interventions.
J Family Med Prim Care
July 2019
Background: Compound tincture benzoin (CTB) is used as a post-procedure skin seal antiseptic agent since ancient times; but this drug is reported to cause allergic contact dermatitis and other unwanted side effects. Our aim of the present study was to compare alternative agent like Medicated Adhesive dressing (MAD) with CTB as a post-procedure skin seal dressing.
Design: This prospective randomized controlled experimental study included an equal number of patients in MAD and CTB as a post-operative seal dressing material for percutaneous interventions.
Background: Dyskinetic neurological diseases are common presentations of adverse reaction to many therapeutic agents. Phenytoin, a widely used age-old antiepileptic drug has been reported to cause dyskinesias, a rare Adverse Drug Reaction (ADR) in adults with toxic therapeutic serum level. When the drug is used in combination with other drugs which augments free drug level of phenytoin or in patients of organic brain lesion, this side effect is very occasionally reported with even normal therapeutic drug level.
View Article and Find Full Text PDF